Alliancebernstein L.P. Denali Therapeutics Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,154,387 shares of DNLI stock, worth $46.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,154,387

Previous 3,315,642 4.86%

Holding current value

$46.2 Million

Previous $67.6 Million 36.51%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$13.6 - $23.59 $2.19 Million - $3.8 Million	-161,255 Reduced 4.86%	3,154,387 $42.9 Million
Q4 2024 Feb 12, 2025	BUY	$20.24 - $31.58 $5.43 Million - $8.48 Million	268,378 Added 8.81%	3,315,642 $67.6 Million
Q3 2024 Nov 14, 2024	BUY	$20.96 - $31.05 $21.6 Million - $31.9 Million	1,028,730 Added 50.96%	3,047,264 $88.8 Million
Q2 2024 Aug 14, 2024	BUY	$14.96 - $23.22 $28.1 Million - $43.7 Million	1,880,914 Added 1366.74%	2,018,534 $46.9 Million
Q1 2024 May 14, 2024	SELL	$15.83 - $23.35 $37,042 - $54,639	-2,340 Reduced 1.67%	137,620 $2.82 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $51,840 - $74,176	3,200 Added 2.34%	139,960 $3 Million
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $865,634 - $1.27 Million	-41,960 Reduced 23.48%	136,760 $2.82 Million
Q2 2023 Aug 15, 2023	BUY	$23.37 - $32.96 $200,047 - $282,137	8,560 Added 5.03%	178,720 $5.27 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $333,032 - $496,584	15,200 Added 9.81%	170,160 $3.92 Million
Q1 2022 May 13, 2022	BUY	$29.0 - $47.27 $8,700 - $14,181	300 Added 0.19%	154,960 $4.99 Million
Q3 2021 Nov 10, 2021	SELL	$48.48 - $78.23 $33,936 - $54,761	-700 Reduced 0.45%	154,660 $7.8 Million
Q2 2021 Jul 30, 2021	BUY	$50.3 - $78.44 $2.96 Million - $4.61 Million	58,760 Added 60.83%	155,360 $12.2 Million
Q1 2021 May 06, 2021	BUY	$53.8 - $81.53 $37,660 - $57,071	700 Added 0.73%	96,600 $5.52 Million
Q4 2020 Feb 08, 2021	BUY	$36.89 - $93.56 $99,603 - $252,612	2,700 Added 2.9%	95,900 $8.03 Million
Q3 2020 Nov 12, 2020	SELL	$23.13 - $38.84 $50,886 - $85,448	-2,200 Reduced 2.31%	93,200 $3.34 Million
Q2 2020 Aug 13, 2020	BUY	$16.01 - $28.82 $384,240 - $691,680	24,000 Added 33.61%	95,400 $2.31 Million
Q1 2020 May 14, 2020	BUY	$14.2 - $27.98 $5,680 - $11,192	400 Added 0.56%	71,400 $1.25 Million
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $29,600 - $45,024	1,600 Added 2.31%	71,000 $1.47 Million
Q4 2018 Feb 13, 2019	BUY	$13.88 - $21.75 $235,960 - $369,750	17,000 Added 32.44%	69,400 $1.43 Million
Q3 2018 Nov 08, 2018	BUY	$12.46 - $21.74 $336,420 - $586,980	27,000 Added 106.3%	52,400 $1.14 Million
Q2 2018 Aug 13, 2018	BUY	$15.25 - $21.02 $387,350 - $533,908	25,400 New	25,400 $387,000

Others Institutions Holding DNLI

# of Institutions

234

Shares Held

127M

Call Options Held

37.3K

Put Options Held

7.9K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.96B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Denali Therapeutics Inc. Transaction History